"this OTA is to develop a cold stored platelet product with extended shelf life up to 21 days, which kill significantly increase the availability of platelets to roles 2 and 3 in theater, decrease…
Active Other Transaction Agreement Awarded Last action
- Contract number
- W81XWH2190014
- Awardee
-
University Of Pittsburgh - Of The Commonwealth System Of Higher Education UEI MKAGLD59JRL1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $31,703,159
Award facts
- Contract value 99% obligated
- $32,142,213.12 Current and potential, with all options
- Completion date 92% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Competition
- Not Competed Only One Source
- Pricing
- Other
- Place of performance
- Pittsburgh, PA 15260, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $598,193 | |
| Other Administrative Action | $131,354 | |
| Supplemental Agreement for work within scope | $5,612,899 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,822,909 | |
| Other Administrative Action | $7,968,818 | |
| Other Administrative Action | $2,886,806 | |
| Other Administrative Action | $5,431,358 | |
| Other Administrative Action | $956,620 | |
| Original award | $6,294,200 |
Show all 11
About this award
The Defense Health Agency awarded an Other Transaction Agreement to the University of Pittsburgh for $32,142,213.12 on September 25, 2021, to develop a cold stored platelet product with extended shelf life up to 21 days that will increase platelet availability to Roles 2 and 3 medical facilities in theater, decrease bacterial growth, and reduce platelet expiration. This OTA sits outside the FAR and operates under alternative transaction authority.
Performance is based in Pittsburgh, Pennsylvania, with an ultimate completion date of March 25, 2027. The effort focuses on chilled stored platelet development as a prototype and product advancement initiative to address critical blood product supply constraints in forward-deployed military medical operations. The University of Pittsburgh is a tax-exempt public research institution within Pennsylvania's Commonwealth System of Higher Education and does not claim SBA socioeconomic designations.
Description
"this OTA is to develop a cold stored platelet product with extended shelf life up to 21 days, which kill significantly increase the availability of platelets to roles 2 and 3 in theater, decrease bacterial growth, and reduce platelet expiration."
Quick answers
Who was awarded contract W81XWH2190014?
W81XWH2190014 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by Defense Health Agency (Department of Defense) on September 25, 2021.
How much is contract W81XWH2190014 worth?
The government has obligated $31,703,159 on W81XWH2190014. Its current value, with exercised options, is $32,142,213.
Was contract W81XWH2190014 competed?
The extent of competition for W81XWH2190014 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award